Drug Development That Moves at the Speed of Change

New benchmarking research from the Tufts Center for the Study of Drug Development (Tufts CSDD), sponsored and commissioned by Syneos Health, examines how clinical sourcing models relate to trial performance and quality. Building on the questions raised by that research, Drug Development That Moves at the Speed of Change looks beyond today’s operating models to consider what clinical development must become next.

The white paper explores four connected dimensions of adaptive drug development: continuous evidence generation, more responsive regulatory engagement, the combined power of AI, data and human expertise, and flexible operating models that can evolve with portfolio needs. Together, these elements create an environment in which trial design, evidence strategy, technology and execution continuously inform one another.

Want to learn more about the Tufts CSDD Sourcing Benchmarking Study? Contact our team.